Searched for
GSK INDIA MD
Scanning cancer, up close & personal: A revolution is underway in cancer diagnosisA gene-based test called next-generation sequencing can identify precise mutations, which can then be treated with targeted therapies. Sinc...- GSK India plans big 'reinvention', MD Bhushan Akshikar revealsGlaxoSmithKline Pharmaceuticals is planning a major comeback in India. The company aims to double its revenue to ₹8,000 crore within the ne...
- GSK enters into oncology segment; launches therapies for gynaecological cancersGlaxoSmithKline Pharmaceuticals has entered the oncology segment in India, introducing Jemperli and Zejula for gynaecological cancers. Thes...
- GSK India Q2 Results: Net profit grows 11% YoY to Rs 216 croreOur Q2 performance reflects an overall recovery with market share gains in several key promoted brands across all business units. We held l...
- GSK India appoints Bhushan Akshikar as managing directorAkshikar with over 26 years experience within the pharmaceutical industry, joined GSK India in September 2011 to lead the specialty and com...
- GSK's pharma brands doing well: India MDThe company is also banking on its dermatology portfolio - a segment where it leads the market with brands such as Betnovate, T-Bact and Te...
- Optimising product portfolio, focusing on key brands: GSK Pharmaceuticals"The business has embarked on it new strategy this year, as we put in place an optimal commercial structure and worked at building capabili...
- Focus on 20 key brands to drive growth: GlaxoSmithKline pharmaceuticalsAs part of its growth plans the company is also planning to aggressively expand its field force.
- GlaxoSmithKline is saying goodbye to Bell Curve appraisalsHR experts feel over the years the traditional performance appraisal mechanism has outlived its utility, and a more robust system is needed.
- Pfizer and GlaxoSmithKline initiate leadership reshuffle in face of competition from domestic playersTop multinational drug makers Pfizer and GlaxoSmithKline have initiated major reshuffle of senior leadership teams in India in face of comp...
- Back in India, GSK Consumer Healthcare’s Manoj Kumar will have to adapt to a different trade modelExperts say while his global experience will be an advantage, it will require a lot more in pushing sales of Horlicks.
- GSK Consumer Healthcare Zubair Ahmed appointed head of Asia Pacific, Middle East and Africa regionAs part of the new role, Ahmed will oversee operations of over 100 countries, joining the growing league of Indians taking on top roles glo...
- Domestic pharma companies may gain as MNCs set to swallow bitter marketing pillA cautious strategy adopted by MNCs in promoting medicines could affect MNCs, including GSK, and impact their growth prospects in the India...
- GSK not under compulsion to buy Indian companies: Hasit JoshipuraGSK will not pay exorbitant price to buy Indian companies as it is under no such compulsions, a top company executive said.
- India, China new profit centres for GSK ConsumerGlaxosmithkline Consumer Healthcare has elevated India and China into separate profit centres that will report directly to its headquarters...
- Glaxo’s plan to acquire 5% stake in Dr Reddy’s may fizzle outUK-BASED GlaxoSmithKline’s (GSK) plan to buy about 5% stake in Dr Reddy’s Laboratories (DRL) for $150-160 million is stuck and unlikely to ...
- ‘Productivity of global pharma R&D pipelines has fallen’The Indian arms of most global pharma giants have so far remained under-sized, rather off their parent’s radar for sometime now. But are th...
- Cipla overtakes GSK to become top Indian pharma companyCipla has established its lead in the domestic pharma retail market to become the no. 1 company for the first seven months this year.
- Glaxo, Ranbaxy expand R&D dealRanbaxy Laboratories announced on Tuesday the signing of a new multi-year R&D agreement with GlaxoSmithKline (GSK), which expands the terms...
- GSK on prowl, to get global productsThe pharma major is close to making key acquisitions in healthcare and OTC and launch new products.
Load More
